BCM
CLX icon

Bayesian Capital Management’s Clorox CLX Stock Holding History

Bayesian Capital Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,900
Closed -$1.75M – 592
2025
Q1 		$1.75M Buy
+11,900
New +$1.82M 0.29% 94
2024
Q4 		– Sell
-26,400
Closed -$4.3M – 726
2024
Q3 		$4.3M Buy
26,400
+6,600
+33% +$978K 0.5% 38
2024
Q2 		$2.7M Buy
19,800
+3,000
+18% +$417K 0.31% 81
2024
Q1 		$2.57M Sell
16,800
-4,700
-22% -$702K 0.25% 115
2023
Q4 		$3.07M Sell
21,500
-6,700
-24% -$893K 0.33% 72
2023
Q3 		$3.7M Buy
28,200
+7,500
+36% +$1.14M 0.42% 57
2023
Q2 		$3.29M Buy
+20,700
New +$3.34M 0.35% 52
2023
Q1 		– Sell
-2,277
Closed -$320K – 827
2022
Q4 		$320K Buy
+2,277
New +$323K 0.05% 464
2020
Q3 		– Sell
-8,644
Closed -$1.9M – 537
2020
Q2 		$1.9M Buy
+8,644
New +$1.73M 0.42% 46
2018
Q1 		– Sell
-3,500
Closed -$521K – 610
2017
Q4 		$521K Sell
3,500
-300
-8% -$40.8K 0.11% 303
2017
Q3 		$501K Buy
+3,800
New +$511K 0.12% 265
2017
Q2 		– Sell
-4,500
Closed -$607K – 452
2017
Q1 		$607K Buy
+4,500
New +$583K 0.29% 117
2016
Q3 		– Sell
-4,354
Closed -$603K – 373
2016
Q2 		$603K Buy
+4,354
New +$565K 0.36% 87
2016
Q1 		– Sell
-2,500
Closed -$317K – 364
2015
Q4 		$317K Buy
+2,500
New +$310K 0.45% 85

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bayesian Capital Management's CLX Position: Q2 2025 in Review

Bayesian Capital Management sold out of Clorox (CLX) in Q2 2025, closing a stake of 11,900 shares — an estimated $1.75M sold.

Bayesian Capital Management first reported a position in CLX in Q4 2015 and held it in 14 quarters. The position peaked at $4.3M in Q3 2024. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Bayesian Capital Management reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 11,900 Clorox shares in Q2 2025, an estimated $1.75M.
  • Bayesian Capital Management first reported a position in Clorox in Q4 2015 and held it in 14 quarters.
  • Bayesian Capital Management's Clorox position peaked at $4.3M in Q3 2024.
  • 1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.